Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

MLYS · ISSUER CIK 1933414

Mineralys Therapeutics, Inc.

Between Aug 1, 2026 and Oct 29, 2026, 8 Mineralys Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $5.5M of sales on SEC Form 4.

SEC insider filings
↗8 insiders filed

Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 5 of 6 sales were reported under a 10b5-1 plan.

$0.00Insider buying
$5.5MInsider selling
−$5.5MNet open-market
Oct 20, 2026Latest filing
Form 4 trades at Mineralys Therapeutics, Inc.
TickerInsiderTypeOwned
Oct 20, 202617:35Oct 19, 2026MLYSDirectorA · Grant—+12,40012,400New—
Oct 20, 202617:32Oct 19, 2026MLYSDirectorA · Grant—+12,40012,400New—
Oct 2, 202617:53Sep 30, 2026MLYSChief Executive Officer, DirectorS · Sell10b5-1$25.46−75,000528,621-12%−$1.9M
Sep 24, 202621:49Sep 22, 2026MLYSDirectorS · Sell$28.81−104,3207,805,718-1%−$3.0M
Sep 22, 202618:48Sep 21, 2026MLYSChief Commercial OfficerS · Sell10b5-1$28.12−7,43838,400-16%−$209K
Sep 22, 202618:48Sep 21, 2026MLYSChief Commercial OfficerM · Exercise10b5-1$13.24+7,43845,838+19%$98K
Sep 17, 202617:41Sep 15, 2026MLYSDirectorS · Sell10b5-1$28.58−3,0006,200-33%−$86K
Sep 17, 202617:41Sep 15, 2026MLYSDirectorM · Exercise10b5-1$12.02+3,0009,200+48%$36K
Aug 25, 202617:16Aug 21, 2026MLYSChief Commercial OfficerS · Sell10b5-1$25.98−7,43738,400-16%−$193K
Aug 25, 202617:16Aug 21, 2026MLYSChief Commercial OfficerM · Exercise10b5-1$13.24+7,43745,837+19%$98K
Aug 12, 202619:33Aug 10, 2026MLYSChief Medical OfficerA · Grant—+102,400102,400New—
Aug 12, 202619:33Aug 10, 2026MLYSChief Medical OfficerS · Sell10b5-1$27.09−2,17051,384-4%−$59K
Aug 12, 202619:33Aug 10, 2026MLYSChief Medical OfficerM · Exercise10b5-1$16.00+2,17053,554+4%$35K
Mineralys Therapeutics, Inc. (MLYS) Insider Trading | Shameless Cloning